Innovation at Scale-Healthy Returns

Since stepping in as CEO just over a year ago, Albert Bourla has already been named America’s top pharmaceutical CEO by Institutional Investor. In a rare interview, CNBC’s Meg Tirrell spoke with him …Powered by...

Property Rights Protect Global Innovation | Opinion

Thanks to this approach, programs like the FDA’s Coronavirus Treatment Acceleration Program have allowed the innovation floodgates to open. To fight coronavirus, there are now over 600 clinical trials …Powered by...